Targeting K-Ras and apoptosis-driven cellular transformation in cancer
Open Access
- 14 April 2021
- journal article
- review article
- Published by Springer Nature in Cell Death Discovery
- Vol. 7 (1) , 1-8
Abstract
Cellular transformation is a major event that helps cells to evade apoptosis, genomic instability checkpoints, and immune surveillance to initiate tumorigenesis and to promote progression by cancer stem cell expansion. However, the key molecular players that govern cellular transformation and ways to target cellular transformation for therapy are poorly understood to date. Here we draw key evidences from the literature on K-Ras-driven cellular transformation in the context of apoptosis to shed light on the key players that are required for cellular transformation and explain how aiming p53 could be useful to target cellular transformation. The defects in key apoptosis regulators such as p53, Bax, and Bak lead to apoptosis evasion, cellular transformation, and genomic instability to further lead to stemness, tumorigenesis, and metastasis via c-Myc-dependent transcription. Therefore enabling key apoptotic checkpoints in combination with K-Ras inhibitors will be a promising therapeutic target in cancer therapy.Keywords
This publication has 94 references indexed in Scilit:
- Redirecting neutrophils against bladder cancer cells by BCG and Smac mimetic combinationOncoImmunology, 2012
- Spherical Bullet Formation via E-cadherin Promotes Therapeutic Potency of Mesenchymal Stem Cells Derived From Human Umbilical Cord Blood for Myocardial InfarctionMolecular Therapy, 2012
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulationNature, 2010
- Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cellsCancer Biology & Therapy, 2010
- Human papillomavirus oncoproteins: pathways to transformationNature Reviews Cancer, 2010
- Isolation of a chemical inhibitor against K-Ras-induced p53 suppression through natural compound screeningInternational Journal of Oncology, 2009
- Epidermal Growth Factor Receptor Signaling Synergizes with Hedgehog/GLI in Oncogenic Transformation via Activation of the MEK/ERK/JUN PathwayCancer Research, 2009
- JNK signaling in apoptosisOncogene, 2008
- Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expressionMolecular Cancer Therapeutics, 2008
- Hemizygous Disruption of Cdc25A Inhibits Cellular Transformation and Mammary Tumorigenesis in MiceCancer Research, 2007